Skip to content
10-Q

Quarterly Report

BIOFORCE NANOSCIENCES HOLDINGS, INC. BFNH

0001091818-24-000049

← back to feed
Filed
May 3, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2024 · May 2, 2024 29.27M sh
Cash And Equivalents Q1 2024 · Mar 31, 2024 $640
Cash And Equivalents Q1 2024 · Dec 31, 2023 $638
Current Liabilities Q1 2024 · Mar 31, 2024 $1.95M
Current Liabilities Q1 2024 · Dec 31, 2023 $1.82M
Total Liabilities Q1 2024 · Mar 31, 2024 $1.95M
Total Liabilities Q1 2024 · Dec 31, 2023 $1.82M
Current Assets Q1 2024 · Mar 31, 2024 $640
Current Assets Q1 2024 · Dec 31, 2023 $638
Total Assets Q1 2024 · Mar 31, 2024 $640
Total Assets Q1 2024 · Dec 31, 2023 $638
Shares Diluted Q1 2024 · Mar 31, 2023 29.27M sh
Operating Cash Flow Q1 2024 · Mar 31, 2023 −$23.05K
Stockholders Equity Q1 2024 · Mar 31, 2023 −$1.48M
Stockholders Equity Q1 2024 · Dec 31, 2022 −$1.35M
Eps Diluted Q1 2024 · Mar 31, 2023 $0.00
Eps Basic Q1 2024 · Mar 31, 2023 $0.00
Sga Expense Q1 2024 · Mar 31, 2023 $24.26K
Net Income Q1 2024 · Mar 31, 2023 −$130.01K